Newsmeme!
Discover News you didn't know existed
Thrombolytic Drugs
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
New EkoSonic™ Endovascular System With Rapid Pulse™ Modulation Technology 4 Times Faster Than Conventional ...
Published September 5, 2008, 9:14 am, Medical News Today
EKOS Corporation announced the launch of the EkoSonic™ Endovascular System (EkoSonic ES) with Rapid Pulse Modulation (RPM) for the dissolution of vascular blood clots. EkoSonic ES is the only endovascular system that can deliver microsonic energy and thrombolytic drugs simultaneously, providing a safer, faster and more complete way to remove clots by accelerating dissolution.
High Growth Forecasted for the In Vitro Diagnostics Market Report and Analysis 2008-2023
Published September 4, 2008, 11:54 am, Marketwire via Yahoo! Finance
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
Medicure Inc.: New Data Shows AGGRASTAT Offers Significant Benefits to Patients with Poor Response to Aspirin and/or ...
Published September 3, 2008, 8:16 am, Marketwire via Yahoo! Finance
Medicure Inc., a cardiovascular focused, biopharmaceutical company, today announced that new data presented at the annual European Society of Cardiology Congress in Munich, Germany showed AGGRASTAT® significantly lowers the incidence of heart attack after elective coronary angioplasty in coronary artery disease patients who have shown poor response to standard oral antiplatelet agents, aspirin ...
New European Guidelines For The Management Of Acute Pulmonary Embolism
Published September 2, 2008, 1:08 pm, Medical News Today
Acute pulmonary embolism (PE) is a relatively common cardiovascular emergency. Clots originating in the leg veins may become detached and obstruct the lung vessels. This obstruction may lead to a rise of pressure in the pulmonary circulation and possibly to life-threatening heart failure. PE is a difficult diagnosis that may be missed because of non-specific complaints.
New European guidelines for the management of acute pulmonary embolism
Published September 2, 2008, 8:25 am, EurekAlert!
( European Society of Cardiology ) Acute pulmonary embolism is a relatively common cardiovascular emergency. Clots originating in the leg veins may become detached and obstruct the lung vessels.
European guidelines for acute pulmonary embolism
Published September 2, 2008, 3:25 am, News-Medical-Net
Acute pulmonary embolism (PE) is a relatively common cardiovascular emergency. Clots originating in the leg veins may become detached and obstruct the lung vessels. This obstruction may lead to a rise of pressure in the pulmonary circulation and possibly to life-threatening heart failure.
New Data Shows Anticlotting Medicine, AGGRASTAT(R), Lowers Incidence of Heart Attack, in Patients Who Respond Poorly ...
Published September 2, 2008, 2:00 am, Business Wire via Yahoo! Finance
PHILADELPHIA----Antiplatelet medicine, AGGRASTAT® , a glycoprotein IIb/IIIa inhibitor, has been shown to significantly lower the incidence of heart attack after elective coronary angioplasty, in patients with coronary artery disease who have shown poor response to standard oral antiplatelet agents such as aspirin and clopidogrel.1 These results were announced today at the Annual European ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |